SEC Form 3 · accession 0000899243-16-019018
AMEDISYS INC · AMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jane Carmody
Officer — See Remarks
Period of report
Apr 20, 2016
Accepted (ET)
May 2, 2016 · 9:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 2,469 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $40.51 | holding | — | — | — | — | Oct 21, 2025 | Common Stock | 4,660 | — | D |
| Restricted Stock UnitsF3 | — | holding | — | — | — | — | — | Common Stock | 7,406 | — | D |
Explanation of responses
- F1Includes 2,469 shares of time-based Restricted Stock Units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 25% installments on each of October 21, 2016, October 21, 2017, October 21, 2018 and October 21, 2019, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs.
- F2The Stock Options are subject to time-based vesting conditions and will vest in equal, 25% installments on each of October 21, 2016, October 21, 2017, October 21, 2018 and October 21, 2019, provided that the Reporting Person remains continuously employed by the issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
- F3The RSUs awarded are subject to performance-based vesting and will vest (i) on the certification by the Compensation Committee of the Issuer's Board of Directors of the achievement of identified performance goals for fiscal year 2015 and (ii) additional time-based vesting conditions (25% installments on each of October 21, 2016, October 21, 2017, October 21, 2018 and October 21, 2019), assuming the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs.
Remarks
Chief Clinical Operations Officer